Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 1.5% 16.875 16.25 17.50 16.875 16.625 16.63 274,064 14:00:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.4 -0.9 - 26

Skinbiotherapeutics Share Discussion Threads

Showing 7626 to 7649 of 8050 messages
Chat Pages: Latest  310  309  308  307  306  305  304  303  302  301  300  299  Older
DateSubjectAuthorDiscuss
19/9/2020
20:46
Pj re your 6614Have to laugh when you say the excesses are being questioned In the House of Commons as being obscene. Are you serious?Presumably you forgot about the mp who claimed £20k for a book cabinet for his library as essential for his work when he was retiring in a few monthsThe guy who had his moat dredged at taxpayers expense The mep's employing their wives, sons and daughters to claim their salaries and expensesPlus a few hundred other examples Whilst I may agree with you on executive greed but to hold up the mp's as the ones questioning this ethic is quite preposterous
gary hindsight
19/9/2020
09:42
These options are an annual thing then and appear to get progressively more generous noting the price of the options in 18th April 2019 RNS were 18p? "Stuart Ashman does not hold any ordinary shares in the Company. On 18 April 2019 Mr Ashman was granted options over 3,892,083 ordinary shares, representing 3% of the current issued share capital of the Company. The options, which have a life of ten years, are exercisable in three equal tranches at a price of 18p per share. The first two tranches can be exercised no earlier than 24 months from the date of grant, and the third tranche no earlier than 36 months from the date of grant. Exercise is subject to achieving performance milestones set by the Company's board which are aligned to growth in shareholder value and commercialisation of the Company's SkinBiotix® technology."
aquaesulis01
18/9/2020
22:41
And they have to wait 24 months to exercise the options which have performance criteria attached to them.
madaboutmed
18/9/2020
21:37
Let’s get a bit of perspective. 1.8m options between them at 9p means they are currently 10p in the money, which is a pre tex profit of £180k, and just over £90k between them after tax. So we are talking about less than £50k each after tax. Not much in the grand scheme of things is it?
blah blah
18/9/2020
21:04
Have you?Don't bother i know the answer.
slartybartfaster
18/9/2020
20:19
Now, now PJ. Everyone invested here will be familiar with what remuneration committees are. I agree with you broadly - it's a racket, especially in the big corporates - but why the questions here, and why now? If the BOD stuff up, I will probably be the first to shout about it - but so far, so good IMO.
lovewinshatelosses
18/9/2020
19:30
So......why additional options to when he joined? Has anyone questioned the Remuneration committee on this? Does anyone actually know what a remuneration committee is? Don't bother, I know what the answer is.
pj 1
18/9/2020
19:20
This team have a crazy low cash burn and seem to do a lot with what little they have at their disposal. I have no problem with options linked to commercial performance as it is good for us all. SA was headhunted and took what he describes in the Elrico interview as a massive pay cut to join here. I would imagine the options were part of his package and as someone said earlier these options were granted some time ago and are simply being reported now. On the plus side it was nice to see the share price move north today.
madaboutmed
18/9/2020
19:13
Most PLC's that have gone bust have had enormous Director Options. Maye to help from deflecting from the ''travelling and other costs''. No inferrance or I wouldn't be invested
pj 1
18/9/2020
18:49
Better that than unjustified enrichment through inflated salaries and bloated package perks, irrespective of share price performance, as is so often seen, especially on AIM. Anyway, as others have said, the initial targets are not excessive so not applicable in this case.
lovewinshatelosses
18/9/2020
18:43
SA thinks 40p is achievable. I'm sure he is right. What price the share price when the anti aging cream is launch by a household name.
slartybartfaster
18/9/2020
18:00
Research. There is clear proof that any Bonus, if not reached , then acts as a demotivator because it becomes unachievable, where employees had predicted and budgeted for it to be awarded, and the result is way below the expected average performance as lethargy kicks in. It works both ways, but, PI's always assume its a positive without the true facts.
pj 1
18/9/2020
17:55
Just think about it, war breaks out and nobody turns up. Frankie Goes to Hollywood.
pj 1
18/9/2020
17:55
According to a podcast with elrico SA took a significant paycut to take the position as CEO. He also explained there are strict targets linked to the share price before these options can be taken up. 40p is 1. Would we be happy with that?
slartybartfaster
18/9/2020
17:47
Overall, Director remuneration has massively exceeded the average for decades, and is actively being challenged in the house of Commons as obscene. Why support it?
pj 1
18/9/2020
17:42
Well The contrarian view then has to be that if options incentivise, then a lack of options is a demotivator? Why isn't a (high) salary enough? Are we saying that Directors do not come to work to do their best without Options? Do we go to work to work as hard as we can, in the hope of getting a pay rise, or do we go to work and do as little as possible until we are paid enough? I know where I sit, why are Directors different?
pj 1
18/9/2020
17:24
Also These aren't new options they are options previously granted which they forgot to report
gary hindsight
18/9/2020
15:59
That statement shows you haven't a clue. Did you actually check and know what the triggers are for them?
slartybartfaster
18/9/2020
15:54
Disappointing to see options priced so cheaply
dekle
18/9/2020
09:34
It only takes a few buys and others jump in, human nature I suppose.
rafboy
18/9/2020
08:54
Yes, it's odd. Nothing much for ages, then suddenly lots of interest.
nik7907
18/9/2020
08:27
Interesting action today with a stream of buys
gary hindsight
17/9/2020
19:34
Hi ElricoCan I please have a coin to join your thread.ThanksOmar
omarmapara1234
12/9/2020
13:50
I miss read. You appears to be guessing both commercial partnerships are about 12 months ahead of schedule. I know from Elrics interview there is expectation both could be launched in H1 2021, poss just before summer? It could get exciting around Xmas new year then.
slartybartfaster
Chat Pages: Latest  310  309  308  307  306  305  304  303  302  301  300  299  Older
ADVFN Advertorial
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201202 22:53:59